Page 8 – Get Rich. Get Richer

The IPO Hangover: Once ‘Hot’ Issues Now Trading Up to 51% Below Offer Price

Rajesh Shah / February 20, 2026

From grey market frenzy to grim reality — after India’s IPO boom, retail investors are nursing losses while promoters cashed […]

admin / February 19, 2026

Aerospace and energy component maker’s calibrated growth strategy and peak utilization by FY28 drive buy ratings despite near-term moderation, Q3

admin / February 19, 2026

Investment bank turns bullish on Indian equities after 2025 underperformance, cites valuation compression to 10-year average, trade deal boost, and

admin / February 19, 2026

India’s fertility treatment market leader seeks Rs 90 crore for expansion as medical tourism set to increasae Gaudium IVF and

admin / February 19, 2026

A 102% surge in defence revenue and Rs 11,130 crore executable order book offset margin pressure from tariffs as brokers

admin / February 19, 2026

Strong Q3 performance and strategic restructuring push brokerages to maintain buy ratings with 20% upside as hospital margins hit 24.8%

admin / February 18, 2026

Infosys tells investors exactly how it plans to win the AI era – and analysts reckon the upside case is

Torrent Pharma delivered a textbook quarter — revenues up 18 per cent year-on-year to Rs 33 billion, profits climbing 26

admin / February 17, 2026

A GST-driven margin surprise and accelerating sales has brokerages agree the growth story has legs Britannia Industries is back in

Team MWP / February 17, 2026

Pharma major’s 284 bps EBITDA margin gain and Unichem turnaround strategy draw bullish analyst calls IPCA Laboratories has emerged as